International Journal of Cancer Management

Published by: Kowsar

Effect of Curcumin on Fatty Acid Synthase Expression and Enzyme Activity in Breast Cancer Cell Line SKBR3

Ommolbanin Younesian 1 , Faranak Kazerouni 1 , * , Nasrin Dehghan-Nayeri 2 , Davood Omrani 3 , Ali Rahimipour 1 , Mehrnoosh Shanaki 1 , Maryam Rezapour Kalkhoran 1 and Fatemeh Cheshmi 1
Authors Information
1 Department of Laboratory Medicine, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Proteomics Research Center, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Department of Medical Genetics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: March 2017, 10 (3); e8173
  • Published Online: March 26, 2017
  • Article Type: Research Article
  • Received: August 7, 2016
  • Revised: September 21, 2016
  • Accepted: March 1, 2017
  • DOI: 10.5812/ijcm.8173

To Cite: Younesian O, Kazerouni F, Dehghan-Nayeri N, Omrani D, Rahimipour A, et al. Effect of Curcumin on Fatty Acid Synthase Expression and Enzyme Activity in Breast Cancer Cell Line SKBR3, Int J Cancer Manag. 2017 ; 10(3):e8173. doi: 10.5812/ijcm.8173.

Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Lv ZD, Liu XP, Zhao WJ, Dong Q, Li FN, Wang HB, et al. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. Int J Clin Exp Pathol. 2014; 7(6): 2818-24[PubMed]
  • 2. Guan F, Ding Y, Zhang Y, Zhou Y, Li M, Wang C. Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation. PLoS One. 2016; 11(1)[DOI][PubMed]
  • 3. Currie E, Schulze A, Zechner R, Walther TC, Farese RJ. Cellular fatty acid metabolism and cancer. Cell Metab. 2013; 18(2): 153-61[DOI][PubMed]
  • 4. Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012; 279(15): 2610-23[DOI][PubMed]
  • 5. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A. 1994; 91(14): 6379-83[PubMed]
  • 6. Liu H, Wu X, Dong Z, Luo Z, Zhao Z, Xu Y, et al. Fatty acid synthase causes drug resistance by inhibiting TNF-alpha and ceramide production. J Lipid Res. 2013; 54(3): 776-85[DOI][PubMed]
  • 7. Hong Y, Qiao JL, Cui LF, Li TX, Zhang JN, Yang SM, et al. Increased expression of FAS is a prognostic marker for patients with breast cancer. Int J Clin Exp Med. 2016; 9(1)
  • 8. Zhou L, Zhao YH, Wang XD, Jiang SF, Li H. [Expression of fatty acid synthase and adipocyte fatty acid-binding protein and the relationship with the clinicopathological characteristics in human infiltrating ductal breast cancer]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015; 46(2): 228-33[PubMed]
  • 9. Yan C, Wei H, Minjuan Z, Yan X, Jingyue Y, Wenchao L, et al. The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells. PLoS One. 2014; 9(5)[DOI][PubMed]
  • 10. Relat J, Blancafort A, Oliveras G, Cufi S, Haro D, Marrero PF, et al. Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer. BMC Cancer. 2012; 12: 280[DOI][PubMed]
  • 11. Khan A, Aljarbou AN, Aldebasi YH, Faisal SM, Khan MA. Resveratrol suppresses the proliferation of breast cancer cells by inhibiting fatty acid synthase signaling pathway. Cancer Epidemiol. 2014; 38(6): 765-72[DOI][PubMed]
  • 12. Fan H, Liang Y, Jiang B, Li X, Xun H, Sun J, et al. Curcumin inhibits intracellular fatty acid synthase and induces apoptosis in human breast cancer MDA-MB-231 cells. Oncol Rep. 2016; 35(5): 2651-6[DOI][PubMed]
  • 13. Fan H, Tian W, Ma X. Curcumin induces apoptosis of HepG2 cells via inhibiting fatty acid synthase. Target Oncol. 2014; 9(3): 279-86[DOI][PubMed]
  • 14. Li P, Tian W, Ma X. Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells. Mol Cancer. 2014; 13: 138[DOI][PubMed]
  • 15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90[DOI][PubMed]
  • 16. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012; 62(4): 220-41[DOI][PubMed]
  • 17. Porta R, Blancafort A, Casoliva G, Casas M, Dorca J, Buxo M, et al. Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients. Menopause. 2014; 21(2): 188-91[DOI][PubMed]
  • 18. Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, et al. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat. 2011; 130(2): 387-98[DOI][PubMed]
  • 19. Zhou L, Jiang S, Fu Q, Smith K, Tu K, Li H, et al. FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration. Oncol Rep. 2016; 35(5): 2715-22[DOI][PubMed]
  • 20. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000; 16(3): 202-8[PubMed]
  • 21. Menendez JA, Lupu R, Colomer R. Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer. Drug News Perspect. 2005; 18(6): 375-85[DOI][PubMed]
  • 22. Puig T, Vazquez-Martin A, Relat J, Petriz J, Menendez JA, Porta R, et al. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75. Breast Cancer Res Treat. 2008; 109(3): 471-9[DOI][PubMed]
  • 23. Richardson RD, Smith JW. Novel antagonists of the thioesterase domain of human fatty acid synthase. Mol Cancer Ther. 2007; 6(7): 2120-6[DOI][PubMed]
  • 24. Puig T, Aguilar H, Cufi S, Oliveras G, Turrado C, Ortega-Gutierrez S, et al. A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines. Breast Cancer Res. 2011; 13(6)[DOI][PubMed]
  • 25. Cheng CS, Wang Z, Chen J. Targeting FASN in Breast Cancer and the Discovery of Promising Inhibitors from Natural Products Derived from Traditional Chinese Medicine. Evid Based Complement Alternat Med. 2014; 2014: 232946[DOI][PubMed]
  • 26. Menendez JA, Mehmi I, Verma VA, Teng PK, Lupu R. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Mol Carcinog. 2004; 41(3): 164-78[DOI][PubMed]
  • 27. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008; 267(1): 133-64[DOI][PubMed]
  • 28. Lai HW, Chien SY, Kuo SJ, Tseng LM, Lin HY, Chi CW, et al. The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: An In Vitro and In Vivo Comparison Study with Herceptin. Evid Based Complement Alternat Med. 2012; 2012: 486568[DOI][PubMed]
  • 29. Yan G, Graham K, Lanza-Jacoby S. Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells. Mol Carcinog. 2013; 52(5): 404-11[DOI][PubMed]
  • 30. Shajan AS. The Effects Of Curcumin On The Expression Of P53 And Bcl-2 Oncoproteins On The Human Breast Carcinoma Cell Line.
  • 31. Palange AL, Di Mascolo D, Singh J, De Franceschi MS, Carallo C, Gnasso A, et al. Modulating the vascular behavior of metastatic breast cancer cells by curcumin treatment. Front Oncol. 2012; 2: 161[DOI][PubMed]
  • 32. Wysham WZ, Roque DR, Han J, Zhang L, Guo H, Gehrig PA, et al. Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines. Target Oncol. 2016; 11(6): 763-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments